Sanford Burnham Prebys Medical Discovery Institute:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sanford Burnham Prebys Medical Discovery Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9350
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sanford Burnham Prebys Medical Discovery Institute (SBP) is a non-profit public benefit institute that offers medical research services. The institute offers research programs in the field of tumor initiation and maintenance, cancer metabolism and signaling networks, tumor microenvironment and cancer immunology, degenerative diseases, immunity and pathogenesis, human genetics development, aging and regeneration, bioinformatics and structural biology, cardiovascular metabolism, integrative metabolism, and genomic control of metabolism. It offers stem cell research and drug discovery technologies. SBP also offers educational services such as postdoctoral training, graduate school and international services. The institute’s technology centers include conrad prebys center for chemical genomics, stem cell research center and translational research institute, among others. It operates through its offices in La Jolla and Orlando, the US. SBP is headquartered in La Jolla, California, the US.

Sanford Burnham Prebys Medical Discovery Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Takeda Pharma Enters into Agreement with Sanford-Burnham 11
Eli Lilly Enters into Research Agreement with Sanford Burnham 12
Sanford Burnham Enters into Co-Development Agreement with Daiichi Sankyo 13
Sanford-Burnham Medical Research Institute Enters Into Research Agreement With Pfizer 14
Mayo Clinic Enters Into Research Agreement With Sanford-Burnham Medical Research Institute 15
Sanford Burnham Enters into Agreement With 60 Degrees Pharma 16
Sanford-Burnham And Florida Hospital Extend Research Agreement With Takeda 17
Sanford-Burnham Medical Enters Into Agreement With Intrexon For Stem Cell Research 19
Moffitt Cancer Center, Sanford-Burnham Medical Research Institute And Florida Hospital Enter Into Partnership To Form Personalized Medicine Partnership of Florida 20
Licensing Agreements 22
Tarrex Biopharma Enters into Licensing Agreement with Sanford Burnham Prebys Medical Discovery Institute 22
Clementia Pharma Enters Into License Agreement With Sanford Burnham Prebys Medical 23
DrugCendR Enters into Licensing Agreement with Sanford Burnham Prebys Medical Discovery Institute 24
Sanford Burnham Prebys Medical Discovery Institute – Key Competitors 25
Sanford Burnham Prebys Medical Discovery Institute – Key Employees 26
Sanford Burnham Prebys Medical Discovery Institute – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Government and Public Interest 28
Sep 26, 2017: SBP scientist receives $10.8 million grant to advance potential drug for substance abuse 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Key Facts 2
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sanford Burnham Prebys Medical Discovery Institute, Deals By Therapy Area, 2012 to YTD 2018 8
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Takeda Pharma Enters into Agreement with Sanford-Burnham 11
Eli Lilly Enters into Research Agreement with Sanford Burnham 12
Sanford Burnham Enters into Co-Development Agreement with Daiichi Sankyo 13
Sanford-Burnham Medical Research Institute Enters Into Research Agreement With Pfizer 14
Mayo Clinic Enters Into Research Agreement With Sanford-Burnham Medical Research Institute 15
Sanford Burnham Enters into Agreement With 60 Degrees Pharma 16
Sanford-Burnham And Florida Hospital Extend Research Agreement With Takeda 17
Sanford-Burnham Medical Enters Into Agreement With Intrexon For Stem Cell Research 19
Moffitt Cancer Center, Sanford-Burnham Medical Research Institute And Florida Hospital Enter Into Partnership To Form Personalized Medicine Partnership of Florida 20
Tarrex Biopharma Enters into Licensing Agreement with Sanford Burnham Prebys Medical Discovery Institute 22
Clementia Pharma Enters Into License Agreement With Sanford Burnham Prebys Medical 23
DrugCendR Enters into Licensing Agreement with Sanford Burnham Prebys Medical Discovery Institute 24
Sanford Burnham Prebys Medical Discovery Institute, Key Competitors 25
Sanford Burnham Prebys Medical Discovery Institute, Key Employees 26
Sanford Burnham Prebys Medical Discovery Institute, Other Locations 27

List of Figures
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Sanford Burnham Prebys Medical Discovery Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • 21st Century Oncology Inc:企業の戦略的SWOT分析
    21st Century Oncology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • First Republic Bank:企業の戦略・SWOT・財務情報
    First Republic Bank - Strategy, SWOT and Corporate Finance Report Summary First Republic Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Progenity Inc:医療機器:M&Aディール及び事業提携情報
    Summary Progenity, Inc. (Progenity) is a US based company engaged in providing specialized diagnostic and complex molecular tests to clinicians. The company offers molecular and diagnostic testing for inheritable cancer, pre-eclampsia and genetic disorders to children and women. It also provides ser …
  • Magellan Midstream Partners LP (MMP):石油・ガス:M&Aディール及び事業提携情報
    Summary Magellan Midstream Partners LP (Magellan Midstream) is a midstream energy company. It transports, stores, and distributes refined petroleum products and crude oil. The company handles various petroleum products such as gasoline, diesel fuel, and crude oil. Magellan Midstream owns and operate …
  • Triveni Turbine Ltd (TRITURBINE):企業の財務・戦略的SWOT分析
    Triveni Turbine Ltd (TRITURBINE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Simplex Infrastructures Ltd:企業の戦略・SWOT・財務分析
    Simplex Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report Summary Simplex Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Jadason Enterprises Limited (J03):企業の財務・戦略的SWOT分析
    Jadason Enterprises Limited (J03) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • BioTime Inc (BTX):製薬・医療:M&Aディール及び事業提携情報
    Summary BioTime Inc (BioTime) is a biotechnology company which focuses on regenerative medicine and plasma volume expanders. The company’s Hextend is a blood plasma volume expander used for the treatment of hypovolemia in surgery, emergency trauma treatment, and other applications. It is also develo …
  • Prologis, Inc.:戦略・SWOT・企業財務分析
    Prologis, Inc. - Strategy, SWOT and Corporate Finance Report Summary Prologis, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Ichor Holdings Ltd (ICHR):企業の財務・戦略的SWOT分析
    Ichor Holdings Ltd (ICHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • United Utilities Group Plc (UU):電力:M&Aディール及び事業提携情報
    Summary United Utilities Group PLC (United Utilities) is a provider of water and wastewater services. It gathers water from reservoirs, lakes, boreholes and streams; and collects and treats wastewater, and deposits it into rivers and sea. The company extracts water from Lake Vyrnwy in Wales for cust …
  • NCC Group PLC (NCC):企業の財務・戦略的SWOT分析
    NCC Group PLC (NCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Kuala Lumpur Kepong Berhad (KLK):企業の財務・戦略的SWOT分析
    Kuala Lumpur Kepong Berhad (KLK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Colefax Group Plc:企業の戦略・SWOT・財務情報
    Colefax Group Plc - Strategy, SWOT and Corporate Finance Report Summary Colefax Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • King Yuan Electronics Co Ltd (2449):企業の財務・戦略的SWOT分析
    King Yuan Electronics Co Ltd (2449) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • EPI Ingredients:企業の戦略・SWOT・財務分析
    EPI Ingredients - Strategy, SWOT and Corporate Finance Report Summary EPI Ingredients - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Minnesota Municipal Power Agency:企業の戦略的SWOT分析
    Minnesota Municipal Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Vectura Group Plc (VEC)-医療機器分野:企業M&A・提携分析
    Summary Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform. It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD) …
  • Zen Technologies Limited:企業の戦略・SWOT・財務分析
    Zen Technologies Limited - Strategy, SWOT and Corporate Finance Report Summary Zen Technologies Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Bio Osmo Berhad:企業の戦略・SWOT・財務情報
    Bio Osmo Berhad - Strategy, SWOT and Corporate Finance Report Summary Bio Osmo Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆